The PROSTATE-IQ trial uses the ArteraAI Prostate Test to personalize treatment for prostate cancer recurrence post-prostatectomy, potentially reducing hormone therapy use. The trial stratifies ...

About 1 in 8 men will get prostate cancer in their lifetime. But a new study concludes an increasing number of men with limited life expectancy are being overtreated for the disease with procedures ...

Prostate cancer patients could have a new treatment on the horizon. A new study published in the journal Nature has found that for some patients with treatment-resistant prostate cancer, a new process ...

Growing evidence indicates that more patients with favorable Grade Group 2 prostate cancer can be successfully managed with active surveillance and achieve acceptable oncologic outcomes, even if later ...

Although overall quality of life was not improved with app support, use of the app had a positive effect on bowel symptoms 3 weeks after treatment. A specialized app that helps with symptom monitoring ...

Effective cancer screening protocols can dramatically alter outcomes for patients. Prostate cancer, for example, has been one of the most common cancers among men in the United States for decades. In ...

Prostate cancer is a type of cancer that develops in the prostate gland. It is a small walnut-sized organ located just below the bladder in men. The prostate gland plays a crucial role in the male ...

A newly expanded prostate cancer drug could bring new hope to patients with a common form of the disease. Novartis, a Switzerland-based pharmaceutical company, announced on March 28 that the U.S. Food ...